Up-regulation of Cyclin D1 by HBx Is Mediated by NF-κB2/BCL3 Complex through κB Site of Cyclin D1 Promoter*

Cyclin D1 is frequently overexpressed in hepatocellular carcinoma (HCC) exhibiting increased malignant phenotypes. It has also been known that the hepatitis Bx (HBx) protein is strongly associated with HCC development and progression. Although overexpression of both proteins is related to HCC, the relationship between the two has not been well studied. Here we show that HBx up-regulates cyclin D1 and that this process is mediated by the NF-κB2(p52)/BCL-3 complex. Our experiments indicate that HBx up-regulates BCL-3 in the mRNA level, which subsequently results in the up-regulation of the NF-κB2(p52)/BCL-3 complex in the nucleus. Moreover, impaired HBx-mediated BCL-3 up-regulation by small interfering RNA for BCL-3 reduced HBx-mediated cyclin D1 up-regulation. Down-regulation of the HBx protein level by p53 also reduced HBx-mediated cyclin D1 up-regulation. From these results, we conclude that the up-regulation of cyclin D1 by HBx is mediated by the up-regulation of NF-κB2(p52)/BCL-3 in the nucleus. This HBx-mediated-cyclin D1 up-regulation might play an important role in the HBx-mediated HCC development and progression.

[1]  G. Jay,et al.  HBx gene of hepatitis B virus induces liver cancer in transgenic mice , 1991, Nature.

[2]  K. Koike,et al.  Interaction of the hepatitis B virus X protein (HBx) with heat shock protein 60 enhances HBx-mediated apoptosis. , 2004, Biochemical and biophysical research communications.

[3]  Sung Gyoo Park,et al.  Antisense Oligodeoxynucleotides Targeted against Molecular Chaperonin Hsp60 Block Human Hepatitis B Virus Replication* , 2003, Journal of Biological Chemistry.

[4]  F. Su,et al.  Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins , 1996, Journal of virology.

[5]  Ramin Massoumi,et al.  Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling , 2006, Cell.

[6]  Y. -. Park,et al.  Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by CRE-decoy oligonucleotide. , 2001, Biochemical and biophysical research communications.

[7]  C. Martínez-A,et al.  The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. , 2002, The Journal of clinical investigation.

[8]  A. Baldwin.  Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. , 2001, The Journal of clinical investigation.

[9]  Michael Karin,et al.  NF-κB in cancer: a marked target , 2003 .

[10]  B. Seong,et al.  Pro‐apoptotic function of HBV X protein is mediated by interaction with c‐FLIP and enhancement of death‐inducing signal , 2003, The EMBO journal.

[11]  A. Graessmann,et al.  HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53 , 2003, Oncogene.

[12]  Sankar Ghosh,et al.  Signaling to NF-kappaB. , 2004, Genes & development.

[13]  S. Murakami.  Hepatitis B virus X protein: a multifunctional viral regulator , 2001, Journal of Gastroenterology.

[14]  A. Zuckerman.  More than third of world's population has been infected with hepatitis B virus , 1999, BMJ.

[15]  G. Ghosh,et al.  Molecular mimicry of the NF-κB DNA target site by a selected RNA aptamer , 2004 .

[16]  N. Perkins,et al.  p53 Represses Cyclin D1 Transcription through Down Regulation of Bcl-3 and Inducing Increased Association of the p52 NF-κB Subunit with Histone Deacetylase 1 , 2003, Molecular and Cellular Biology.

[17]  Q. Su,et al.  Expression of hepatitis B virus X protein in HBV‐infected human livers and hepatocellular carcinomas , 1998, Hepatology.

[18]  B. Slagle,et al.  Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene , 1996, Molecular carcinogenesis.

[19]  C. Sherr.  Cancer Cell Cycles , 1996, Science.

[20]  Mike Rothe,et al.  IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .

[21]  S. Ghosh,et al.  The Phosphorylation Status of Nuclear NF-ΚB Determines Its Association with CBP/p300 or HDAC-1 , 2002 .

[22]  C. Der,et al.  Integration of Rac-dependent Regulation of Cyclin D1 Transcription through a Nuclear Factor-κB-dependent Pathway* , 1999, The Journal of Biological Chemistry.

[23]  G. Acs,et al.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[24]  S. Westerheide,et al.  The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition , 2001, Molecular and Cellular Biology.

[25]  Tae-Wook Chung,et al.  Hepatitis B viral HBx induces matrix metalloproteinase‐9 gene expression through activation of ERKs and PI‐3K/AKT pathways: Involvement of invasive potential , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Kwang-Hyun Cho,et al.  The influence of the signal dynamics of activated form of IKK on NF‐κB and anti‐apoptotic gene expressions: A systems biology approach , 2006, FEBS letters.

[27]  Sung Gyoo Park,et al.  Human Hepatitis B Virus Polymerase Interacts with the Molecular Chaperonin Hsp60 , 2001, Journal of Virology.

[28]  Soon B. Hwang,et al.  Interferon-γ Inhibits Hepatitis B Virus–Induced NF-κB Activation Through Nuclear Localization of NF-κB–Inducing Kinase , 2005 .

[29]  F. Zoulim,et al.  Woodchuck hepatitis virus X protein is required for viral infection in vivo , 1994, Journal of virology.

[30]  Chenguang Wang,et al.  Minireview: Cyclin D1: normal and abnormal functions. , 2004, Endocrinology.

[31]  W. Caselmann,et al.  Molecular Mechanisms of Hepatitis B Virus-Associated Liver Cancer , 2002, Digestive Diseases.

[32]  M. Ozturk.  Genetic Aspects of Hepatocellular Carcinogenesis , 1999, Seminars in liver disease.

[33]  D. Min,et al.  Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1 , 2005, Oncogene.

[34]  Seung-Oe Lim,et al.  The Hepatitis B Virus X Protein Up-regulates Lymphotoxin a Expression in Hepatocytes , 2004 .

[35]  C. Seeger,et al.  Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  F. Sánchez‐Madrid,et al.  The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner , 2001, Oncogene.

[37]  K. Helin,et al.  The E2F family: specific functions and overlapping interests , 2004, The EMBO journal.

[38]  M. Seto,et al.  Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma , 1999, Journal of Gastroenterology.

[39]  C. Seeger,et al.  Hepatitis B Virus Biology , 2000, Microbiology and Molecular Biology Reviews.

[40]  M. Feitelson.  Hepatitis B virus in hepatocarcinogenesis , 1999, Journal of cellular physiology.